Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
Syros Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 21, 2022
Syros Pharmaceuticals reported fiscal year 2021 executive compensation information on April 21, 2022.
In 2021, four executives at Syros Pharmaceuticals received on average a compensation package of $2.2M, a 32% increase compared to previous year.
Average pay of disclosed executives at Syros Pharmaceuticals
Nancy Simonian, Chief Executive Officer, received $3.1M in total, which increased by 23% compared to 2020. 70% of Simonian's compensation, or $2.2M, was in option awards. Simonian also received $323K in non-equity incentive plan, $616K in salary, as well as $576 in other compensation.
Jason Haas, Chief Financial Officer, received a compensation package of $2.5M. 95% of the compensation package, or $2.4M, was in option awards.
David A. Roth, Chief Medical Officer, earned $1.6M in 2021, a 35% increase compared to previous year.
Eric R. Olson, Chief Scientific Officer, received $1.4M in 2021, which increases by 20% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 21, 2022.